chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt left arm pain immediately following the vaccination. Patient reports it became worse, causing restricted ROM and swelling at the site. Patient reports this increased over the last 3 weeks causing considerable pain to the left shoulder. Patient was seen in office and MRI of shoulder was ordered.
Body aches, nausea, chills, headache, and fatigue; Body aches, nausea, chills, headache, and fatigue; Body aches, nausea, chills, headache, and fatigue; Body aches, nausea, chills, headache, and fatigue; Body aches, nausea, chills, headache, and fatigue; This is a spontaneous report from a non-contactable other health care professional. A 26-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), first dose via an unspecified route of administration on an unspecified date at SINGLE DOSE; then second dose (lot number: El1243) via intramuscular on 12Jan2021 14:30 at SINGLE DOSE on arm right for COVID-19 immunization. Medical history included allergy: Ni, covid-19 on an unspecified date.  The patient's concomitant medications were not reported. On 13Jan2021 05:15, the patient experienced Body aches, nausea, chills, headache, and fatigue. The patient did not receive treatment for the events. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
sore arm; This is a spontaneous report received from contactable reporter (consumer or other non-healthcare professional). The reporter is the patient.  A 69-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administered in arm right, administration date 23Feb2021 (Lot number: EL6202) at the age of 69 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "primary adrenal insufficiency" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: HYDROCORTISONE; FLUDROCORTISONE; LEVOTHYROXINE; VITAMINS C; VITAMINS D3; CALCIUM CITRATE; ZYRTEC ALLERGY; FISH OIL. Past drug history included: Ceftin, reaction(s): "Ceftin: Allergy"; Ceclor, reaction(s): "Ceclor: allergy". Vaccination history included: Covid-19 vaccine (dose 1, single, lot number: EL9264, administration time: 05:15 AM, vaccine location: right arm), administration date: 01Feb2021, when the patient was 69 years old, for COVID-19 immunisation, reaction(s): "heat sensation in my right arm from my wrist to my elbow", "sore arm", "unusual feeling". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". Additional information: The patient had no other vaccine in four weeks. Patient had no COVID prior vaccination and patient had no COVID tested post vaccination.   No follow-up attempts are possible. No further information is expected.
Pt received Hep-B #3 on 2/13/02 in the left deltoid, IM. On 2/15/02, mother called our office to describe the reaction developing on his left deltoid. There was a small swelling and redness and was informed to monitor. On 2/16/02, mother called office indicating increased swelling and redness. Pt treated in office on 2/16/02 for early cellulitis secondary to Hep-B vaccine. Treated with Keflex and Atarax.
Patient presented to clinic 2 days post injection. C/O pain 8/10 at injection site. Palpable "lump" 1" in circumference with red area noted to be 1 3/4" round. Warm painful to touch.
Client had reaction to vaccines after walking out to front desk to check out. Diaphoretic, pale, bp/pulse thready @ 77/23, stated he felt like he was in a tunnel. Stated he could not see. When questioned further he stated he could not see anything at all. tried to keep calm. Cool compress applied and fanned and stated some relief but remains very pale and cool. Lips pale, color greenish hue. Squad called after he stated he could not see and by the time they arrived his sight had returned, first with shades of gray then blurry images and then full sight. Vitals by squad 108/76 with pulse ox of 98%. Color returned, stated he felt much better, walked around the room by sqaud personnel. Dad declined services of squad to transport to ER for further evaluation. His wife is a nurse at the hospital and he called her and he is going to take him there to see her and follow up if needed. Client had good color and alert and oriented when he left the premises.
Fatigue, sore throat, headache, dizziness, body aches, joint pains, injection site pain, tiredness.
Diarrhea, nausea, fatigue, body aches, chills, vomiting
Right foot ankle and right leg feeling of numbness and tingle after vaccine. 15 mins. and the numbness and tingle sensation has lasted 2 days after vaccine administration. vaccine saturday March 20 2021 12:50pm sideffect of leg numbness and tingling still present 3/22/2021 ibprofane taken to help any inflamation. sideffects could be related to joint pain. joint in the ankle and knees. the numb and tingle sensation would travel up and down the leg. no discoloration or swelling visible just numbness in the right leg. shot was given on the right arm.  right leg numbness and tingle feeling does seem to be getting better
Nurse administered Vaccine and client passed out and started to slide off chair to the left. This nurse caught client by right arm and pulled him upright in chair. Client was slumped over in chair until nurse popped ammonia Ampule and placed by nostrils to smell. Client had minimal involuntary contractions during incident. v/s at 16:27: B/P: 82/40 HR: 64% R:16 O2:98%. Client came to and was responsive to Verbal stimuli. Gave water, snacks, v/s at 16:40 B/P: 90/70 HR: 63 O2: 95% R:16. Client states that this happens a lot after any medical procedure or shot. Client alert and verbally responsive; eating snacks. V/s at 16:55 B/P 98/68 HR: 98/68, R: 17, O2:97%. Client alert and oriented x3, Verbally responsive. states that he is feeling well, and a lot better, and has notified mom of his incident.
After receiving vaccine patient started to feel hot and face turning red. She reported feeling like she was tight in the chest and throat was swelling. She said she had an epi pen with her. I asked her if she thought it was time to administer and call 911 she said yes. We proceeded. She said her throat was feeling a little better but chest was tight and she was having a dry cough. Ambulance took her to hospital. I called her around Noon the next day to check in on her and she said she was in hospital still being monitored. Was advised not to get second dose of vaccine from hospital.
Field visit: Went to home to vaccinate older sibling (sibling was on our list for 2nd vac due) mother/guardian requested this child and 2 other children needed their covid vaccine also.  Other sibling were terrified and restless or crying before shots administered. I went through the forms and authorization to consent with mom. She stated patient was recently placed in their home and they(she and her spouse) had guardianship over her now, also that patient and the their natural daughter were very close in age and that always confuses here. She gave the the DOB of the child being 5  same as her son. But after I administered vaccine and entered data in EHR patient was 1 month and 2 wks short of being 5 years old.
Information has been received from a registered nurse concerning a 10 year old white female who on 03-MAY-1996 (also reported as 13-OCT-2000) was vaccinated with a dose of Varivax (lot# not reported). On 04-APR-2006 the patient developed varicella infection with less than 50 lesions. The patient also had a fever. No treatment was given. Subsequently, the patient recovered. There was no product quality complaint involved. No additional information is expected.
Headache, vomiting day of vaccine. Numbness (started on my left side of face then moved to my right side). Blurred vision, trouble blinking (lagging).
I tested positive for COVID-19 on 6/22/22. At first, I thought it was allergies or hay fever.  I had sever congestion on 6/21/22. The next day,  6/22/22,  I was still congested with a terrible headache, sore throat, and post nasal drip. That is when I tested myself with 2 at home test and they both came back positive . I contacted my doctor and the told me I qualified for Paxlovid and I went to pick it up and started it that day.
no additional AEs; MMR II that underwent multiple temperature excursions were administered; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug allergies or reactions were not reported.   On 12-MAY-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA)(strength, dose and route were not reported, lot # S020162, expiration date: 30-JUN-2021) for prophylaxis (product storage error).         It was reported that the suspect vaccine was exposed to temperatures of minus 58 Fahrenheit (F) to 46 F for a 1 hour 53 minutes 0 seconds; 56.3 F for 0 hours 48 minutes 0 seconds; 47.8 F for 0 hours 11 minutes 0 seconds; 47.8 F 0 hours 5 minutes 0 seconds, as recorded by the digital data logger. Previous excursions included 57 F for 1 hour 53 minutes 0 seconds; 56.3 F for 0 hours 48 minutes 0 seconds; 47.8 F for 0 hours 11 minutes 0 seconds. No additional adverse event (AE) information was provided.   This is one of the multiple reports reported by the same reporter. ; Sender's Comments:  US-009507513-2106USA007355:
Fatigue and lightheadedness 2 hrs after vaccination for two days Fever onset 8 hours after vaccination, peaking at 104F lasting 14 hours Chills onset 8 hours after vaccination lasting 18 hours Headache onset 24 hours after vaccination lasting one day
neurothopy for 1-2 days; bone pain; Exhaustion; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via unspecified route of administration on unspecified date at age of 60 years old at single dose for COVID-19 immunisation. Patient had chemotherapy for ovarian cancer in 2020. Concomitant medications were not reported. Patient experienced exhaustion, bone pain, neurothopy for 1-2 days post first vaccine. Event took place after use of product. Outcome of events was unknown.  Information on the lot/batch number has been requested.
Reported to me by another PT on about 4/23/07 that patient had died and autopsy was consistent with SIDS. Parents have not returned our calls.  6/21/07 Received vax record from PCP which confirms RO lot & dose number as reported.  8/10/07 Received autopsy report which reveals COD as Undetermined & manner of death as undetermined.  Final dx: infant w/age appropriate weight & development found unresponsive while co-sleeping in adult bed in prone sleeping position.
Ran high fever for 2 day, Mach 13-14, 2010. Fever got up to 103 degrees several times. Took TYLENOL but fever did not get below 101.4 until 3rd day.
Swelling, redness, rash, heat and pain in lower arm below elbow half way to wrist. Awoke with pain Sunday May 2nd and a red spot on forearm about the size of a 50 cent piece. Monday 5/3 started to spread down the side of my arm, I started icing it and it continued to enlarge. Thur May 6, 2021  was the worst day swelling had dropped down in my arm and made elbow swollen and very tender also. Today May 7 my arm is slightly better but still red rash, swollen and hurts.
No adverse event; Administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 77-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 16-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.).    No concomitant medications were reported.   Before use date reported was 15-Dec-2022.  No treatment details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Patient details and vaccination details were updated. On 24-Jan-2023: Live follow-up contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master Case
Patient was administered PCV 13 & varicella on 5/22/2012, 2 days later mother noted a elevated red bump at site of administration of vaccines. On 5/31/2012 diffuse rash entire body. Pt tx 6/1/2012 with BENADRYL & Prednisone. Pt to be seen on 6/5/2012. ER precautions given.
Grande mal seizure, l hand, body stiff for 7 seconds then tired post ictal, felt weak.
On the morning of Saturday April 17 2021, I developed Covid Arm. My arm turned beet red at the injection site. The redness spread out almost up to the shoulder and almost down to the elbow. In addition, the area was very tender, lumpy, hard in spots, and hotter than the rest of my skin. Also, the injection site is now starting to peel like I have a bad sunburn and the peeling is mostly concentrated in what I assume is the bull's eye area of where the injection was delivered into the skin.. It' almost a week later (Friday April 23, 2021) and I still have redness, peeling, and tenderness.
Sore arm the day following the vaccination - nothing unusual.  4 days following the vaccine, patient experienced an onset of moderate diarrhea, which lasted for 5 days.  In addition mild swelling and redness appeared at the site of the vaccination, also lasting for 5 days. Mild nausea accompanied the diarrhea  intermittently.
The night before receiving the Moderna patient's BP was 144/74.  Received shot at 9AM 2/5/2021.  At 3PM felt "jittery".  BP 175/75.  Client states BP kept climbing so went to the ambulance station.  Client states at the ambulance BP was around 215/100>  Was taken to Hospital per ambulance the evening of 2/5/2021.  Note:  Client was on Amlodipine until 1/26/2021 when it was discontinued.  There is a question if the BP elevation was related to the discontinuation of the Amlodipine or the vaccination with Moderna.
Bullae and vesicle development, induration, and redness to posterior arm where Jynneos was injected; Bullae and vesicle development, induration, and redness to posterior arm where Jynneos was injected; Bullae and vesicle development, induration, and redness to posterior arm where Jynneos was injected; Case reference number US-BN-2022-004858 is a spontaneous case report initially received from a nurse on 01-Dec-2022 and concerns a patient of unknown demographics.  The patient's relevant medical history and concomitant medication details were not provided.  On 16-Nov-2022, the patient was vaccinated with the first dose of Jynneos (smallpox and monkeypox vaccine, live modified vaccinia virus ankara; batch number not provided) administered subcutaneously at a dose of 0.5 mL, at an unknown site of administration for an unknown indication.  On an unspecified date, an unknown amount of time after the first dose, the patient developed a significant localized reaction, including bullae and vesicles development, induration and redness to posterior arm where Jynneos was injected.  At the time of this report, the outcome of the events 'blister', 'induration' and 'erythema' was unknown.   The reporter did not provide seriousness or causality assessment.  No further information was provided.; Reporter's Comments: A patient of unknown demographics developed a significant localized reaction including bullae and vesicles development, induration and redness to posterior arm (where Jynneos was injected), within approximately two weeks after vaccination with the first dose of Jynneos. Blister is unlisted and unexpected while injection site induration and injection site erythema are both listed and expected according to RA v1 and RA for Jynneos. The outcome of all reported events was unknown. The patient's relevant medical history and concomitant medication details were not provided. All reported events are assessed as related due to compatible temporal relationship, known product safety profile (for injection site erythema and injection site induration) and since contributory role of the suspect product cannot be excluded. The case is non-serious.; Sender's Comments: A patient of unknown demographics developed a significant localized reaction including bullae and vesicles development, induration and redness to posterior arm (where Jynneos was injected), within approximately two weeks after vaccination with the first dose of Jynneos. Blister is unlisted and unexpected while injection site induration and injection site erythema are both listed and expected according to RA v1 and RA for Jynneos. The outcome of all reported events was unknown. The patient's relevant medical history and concomitant medication details were not provided. All reported events are assessed as related due to compatible temporal relationship, known product safety profile (for injection site erythema and injection site induration) and since contributory role of the suspect product cannot be excluded. The case is non-serious.
Fatigue Narrative:  Severe fatigue; inability to stay awake and eyes were being forced closed.
Achy; Pain in arm; Fever; Chills; Headache; nausea; Lightheaded; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN)  via an unspecified route of administration in the right arm on 24Mar2021 at 12:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient medical history included many (unspecified details).The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 12:15 PM(at the age of 51-years-old)  as a single dose for COVID-19 immunisation.  The patient had allergies to medications, food, or other products. The patient received unspecified medication within 2 weeks of COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19.On 25Mar2021 the patient at 01:30, experienced achy, pain in arm, fever, chills, headache, lightheaded and nausea. The patient did not receive any treatment for the events. The clinical outcome of  achy, pain in arm, fever, chills, headache, lightheaded and nausea was recovering at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
she felt dizzy and nausous. in few minutes, she felt hot. She set down for 15 min and we gave her ice pack and water. She felt better and left.
got the vaccine and then ended up getting shingles; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 10-Jul-2022 Reporter's Comments: The patient's mother/father in law reported the case via interactive digital media. The reporter stated that her/ his son in law got the vaccine and then ended up getting shingles. The patient said that he never again to these New vaccines. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR105409:tag at post US-GLAXOSMITHKLINE-US2022AMR105416:tag at post
Within 10 minutes of receiving vaccine, the patient became hot and sweaty, felt like pins and needles sticking and itching all over, felt as if he couldn't breathe.  BP 184/143.  He then began projectile vomiting. I administered and epipen (one dose) and had pharmacy staff call 911.  He began  feeling better within a couple of minutes, and by the time EMT's arrived, his BP back down to 118/73 and he stated he felt fine.  They transported him to the ER. I called patient approx 6 hours later.  He stated that he was home without further treatment from the ER and felt fine.
Felt Cold tingling in 4th and 5th Fingers to right hand Narrative:  Pt at on site 15min observations immediately after receiving Covid-19 Vaccination Informed monitor staff of 4th and 5th finmgers on right have felt cold Monitor checked VS: BP=134/85 P=73 O2-98% BP=127/74 P=73 BP-115-75 P=73 O2-am98% Situation resolve by 1045
Patient was given PNEUMOVAX morning approximately equal to 10 AM 8/4/09, by that afternoon arm became sore with diminished R.O.M. following morning she noted rash at injection at that time had fever, increase HR, increase BP within 6day Sx resolve.
1 1/2 hours after receiving COVID-19 booster vaccination developed a non-progressive, constant throbbing headache [moderate to severe intensity] and associated with nausea, emesis[x1], photophobia, rotational vertigo, generalized malaise, fever 102.1 and lumbar bilateral pain.  Came to the ED and was admitted to the hospital 1/20/21 for pain control.
This case was reported by a healthcare professional and described the occurrence of red raised welt at injection site in an adult subject of unspecified gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On 19 September 2014, the subject received unspecified dose of FLULAVAL (.5 ml, unknown route and unknown deltoid). On 20 September 2014, 1 day after vaccination with FLULAVAL, the subject experienced red raised welt at injection site. At the time of reporting, the even was improved after 3 days. This case is one of the 5 cases reported by the same reporter for the same vaccine.